FibroBiologics, Inc. (FBLG) stock

FBLGNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 2/30

$0.93−0.04 (-4.21%)

Close on Nov 13, 2026Market cap $6.17MP/E –Yield –

FibroBiologics statistics

60 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $6.17M; $272.32M
Enterprise Value: $2.66M; $146.23M
PB Ratio: 1.33; 2.00
P/TBV Ratio: 1.33; 2.22

Share statisticsIndustry

Shares Outstanding: 7M; 58M
Shares Change (YoY): 112.8%; 10.8%
Shares Held by Institutions: 4.28%; 56.4%

Short sellingIndustry

Short Interest: 334,123; –
Short Interest Change: 1.08%; -0.80%
Short % of Shares Outstanding: 5.02%; 6.30%
Days to Cover: 3.12; 5.15

Stock price statisticsIndustry

52-Week High: $9.60; –
52-Week Low: $0.62; –
20-Day Moving Average: $0.96; –
50-Day Moving Average: $1.18; –
200-Day Moving Average: $2.08; –
Average True Range (14): $0.09; –
Price Change (1 Week): -5.36%; -1.15%
Price Change (1 Month): -7.29%; -4.87%
Price Change (3 Months): -9.11%; -21.0%
Price Change (6 Months): -11.7%; -20.6%
Price Change (YTD): -79.4%; -23.6%
Price Change (1 Year): -85.9%; -22.4%
Average Volume (10 Days): 55,260; –
Average Volume (20 Days): 85,605; –
Average Volume (90 Days): 172,685; –
Relative Volume: 0.21; 0.70
Relative Strength Index (14): 41.2; 43.4
Volatility (1 Year): 128.4%; 80.1%
Beta (5 Years): 0.38; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -660.1%; -49.9%
Return on Assets (ROA): -166.1%; -40.6%
Return on Capital Employed (ROCE): -292.7%; -37.9%

Financial positionIndustry

Current Ratio: 2.64; 3.30
Quick Ratio: 1.59; 2.39
Interest Coverage: -77.81; -6.35

EfficiencyIndustry

Profits Per Employee: -$1.21M; -$689.41K
Employee Count: 15; 74
WACC: 7.60%; 10.2%

Income statement (TTM)Industry

Operating Income: -$16.73M; -$21.37M
Net Income: -$18.14M; -$22.35M
EBITDA: -$16.73M; -$17.21M
EPS (Diluted): -$5.67; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $3.52M; $68.68M
Net Cash (Debt): $3.52M; $17.76M
Net Cash Per Share: $0.53; $0.80
Equity (Book Value): $4.64M; $53.89M
Book Value Per Share: $0.70; $1.50
Tangible Book Value: $4.64M; $27.13M
Working Capital: $3.64M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$14.79M; -$12.38M
Capital Expenditures: -$6.00K; -$1.00M
Free Cash Flow: -$14.80M; -$18.21M
FCF Per Share: -$2.22; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -293.9%; -21.8%
FCF Yield: -239.7%; -9.44%

Taxes and interestIndustry

Interest Expense: $215.00K; $2.90M
Income Tax: $0; $73.00K

Scores and fair valueIndustry

Altman Z-Score: -16.46; 0.23
Piotroski F-Score: 2; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	FBLG	S&P 500	Difference
1 month	-3.4%	-3.0%	−0.4 pts
3 months	-19.4%	-2.8%	−16.6 pts
Year to date	-79.4%	+11.5%	−90.9 pts
1 year	-86.2%	+13.5%	−99.7 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M FBLG shares were sold short on Oct 30, 2026, up 1.1% from the previous report. At recent volumes it would take 3.1 days to buy them back. Over the last 20 sessions, 49.7% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	334,123	+1.1%	106,998	3.1
Oct 15, 2026	330,551	-36.7%	140,541	2.4
Sep 30, 2026	522,114	-21.1%	136,516	3.8
Sep 15, 2026	661,912	+60.0%	357,923	1.9
Aug 31, 2026	413,742	+192.0%	294,961	1.4
Aug 14, 2026	141,714	+23.0%	248,372	1.0
Jul 31, 2026	115,200	+62.6%	90,907	1.3
Jul 15, 2026	70,837	-47.8%	59,556	1.2
Jun 30, 2026	135,794	-0.9%	260,529	1.0
Jun 15, 2026	137,027	+1.1%	148,389	1.0
May 29, 2026	135,591	-42.9%	99,753	1.4
May 15, 2026	237,640	+100.7%	563,635	1.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?